Patents by Inventor Yining XU

Yining XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220402918
    Abstract: The disclosure relates to an indolo[2?,3?:3,4]pyrido[2,1-b]quinazoline compound represented by general formula (I) and use thereof in the manufacture of (1) a medicament for treating a cardiovascular and cerebrovascular disease, (2) a formulation for increasing expression of AMPK, ABCA1 and SR-BI, (3) a formulation for activating nuclear receptors (NRs), and inhibiting activity of NLRP3, IL-1?, NF-?B and MAPKs, (4) a formulation for promoting cellular cholesterol efflux; or (5) a medicament for anti-inflammation.
    Type: Application
    Filed: September 27, 2020
    Publication date: December 22, 2022
    Inventors: Shuyi SI, Yanni XU, Xiao WANG, Jinque LUO, Yongzhen LI, Chao LIU, Xinhai JIANG, Yining LI, Xiaowan HAN, Yan LI, Minghua CHEN, Jing ZHANG, Xin ZHEN
  • Publication number: 20220353231
    Abstract: Embodiments of the present disclosure disclose a message processing method performed by a mobile device. The method may include: displaying a target social networking state mark of a target user on a social networking page of a social networking application, the target social networking state mark being determined according to a preset target option related to the target user, and the target social networking state mark being used for representing the current social networking state of the target user; and displaying a target message related to a trigger event matching the target option in the social networking application when the trigger event is detected based on an update to at least one parameter of the mobile device.
    Type: Application
    Filed: July 18, 2022
    Publication date: November 3, 2022
    Inventors: Dan HE, Yining CAI, Liqiang LIU, Ailu DENG, Zhuo XU
  • Publication number: 20220347111
    Abstract: A lipid nanocapsule for oral administration including a solid lipid outer shell and a lipophilic liquid inner core having reverse micelles loaded with one or more incretin mimetics. Also, a method for treating and/or preventing a disorder associated with a GLP-1 dysfunction, the method including a step of administering the therapeutically effective amount of the lipid to a subject in need thereof.
    Type: Application
    Filed: May 27, 2020
    Publication date: November 3, 2022
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Ana BELOQUI, Yining XU, Véronique PRÉAT, Patrice CANI
  • Publication number: 20220290211
    Abstract: Disclosed is a method of determining a bacterial strain suitable for treating a human skin dysbiotic condition, comprising a step of doing network analysis by a computer to determine the connectivity of said bacterial strain with at least a second bacterial strain in a dysbiotic condition as well as a non-dysbiotic condition, wherein there is difference in said connectivity between said dysbiotic condition and said non-dysbiotic condition wherein said connectivity means a positive correlation or negative correlation and further wherein said network is generated by co-occurrence analysis of abundance of said bacterial strain and said second bacterial strain by DNA sequencing by following 16s rRNA amplicon or whole genome sequencing method.
    Type: Application
    Filed: August 20, 2020
    Publication date: September 15, 2022
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Chung-Ching CHU, Mingming PU, Yining XU
  • Patent number: 11427748
    Abstract: A mussel bionic gel composition includes: a mussel bionic copolymer and/or a mussel bionic compound, a cross-linking agent and water, wherein the mussel bionic copolymer includes a structural unit A from a vinyl monomer and a structural unit B from a vinyl-containing mussel bionic catechol group monomer; and the mussel bionic compound includes polyacrylamide and a mussel bionic catechol compound. The self-growth gel particle profile control and water plugging agent prepared from the composition is low in initial apparent viscosity, easy to inject and far in migration, has good shear repairing performance and is particularly applicable to a low-permeability fractured reservoir, thereby adjusting a micro-fracture network, improving a fracture channel and increasing waterflood efficiency and recovery efficiency.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: August 30, 2022
    Assignee: China University of Petroleum (East China)
    Inventors: Caili Dai, Lin Li, Jiawei Liu, Zhongzheng Xu, Guang Zhao, Mingwei Zhao, Yining Wu, Yongpeng Sun
  • Publication number: 20220226213
    Abstract: The present invention relates to Use of thymol or terpineol or an analogue of thymol or terpineol in a topical composition el for balancing microbiota of amenable skin, where balancing means selectively reducing microbial count of at least one genus of harmful microbes or of at least one genus of microbes that exhibit abnormal growth, while selectively increasing microbial count of at least one genus of beneficial microbes or of at least one genus of microbes whose numbers have abnormally reduced.
    Type: Application
    Filed: May 26, 2020
    Publication date: July 21, 2022
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Chung-Ching CHU, Mingming PU, Yining XU
  • Publication number: 20200360260
    Abstract: Disclosed is a topical composition comprising an antimicrobial lipid found in the sebum or stratum corneum of human beings, other than saturated C8 to 18 fatty acids, wherein said composition further comprises a biphenol obtainable from Magnolia spp.
    Type: Application
    Filed: November 15, 2018
    Publication date: November 19, 2020
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Chung-Ching CHU, Mingming PU, Yining XU